Related Experiment Video

Updated: Aug 1, 2026

Using the BLT Humanized Mouse as a Stem Cell based Gene Therapy Tumor Model
06:59

Using the BLT Humanized Mouse as a Stem Cell based Gene Therapy Tumor Model

Published on: December 18, 2012

FHIT gene therapy prevents tumor development in Fhit-deficient mice

K R Dumon1, H Ishii, L Y Fong

  • 1Kimmel Cancer Center, Jefferson Medical College, 233 South 10th Street, Philadelphia, PA 19107, USA.

Proceedings of the National Academy of Sciences of the United States of America
|March 15, 2001
PubMed

Insights

Oral gene therapy using FHIT gene transfer inhibited tumor development in mice prone to cancer. This approach shows promise for both treating and preventing human cancers.

Area of Science:

  • Oncology
  • Molecular Biology
  • Gene Therapy

Background:

  • The tumor suppressor gene FHIT (Fragile Histidine Triad) is frequently inactivated in various cancers.
  • FHIT inactivation is linked to susceptibility to environmental carcinogens and development of premalignant and malignant lesions.

Purpose of the Study:

  • To investigate the potential of FHIT gene therapy for cancer prevention and treatment.
  • To evaluate the efficacy of oral gene transfer of the FHIT gene in a preclinical cancer model.

Main Methods:

  • Utilized heterozygous Fhit(+/-) knockout mice, which are predisposed to tumor development.
  • Administered oral gene transfer using adenoviral or adeno-associated viral vectors expressing the human FHIT gene.

Main Results:

  • Successfully inhibited tumor development in the Fhit(+/-) mice following carcinogen exposure.
  • Demonstrated the feasibility of oral gene delivery for FHIT expression.

Conclusions:

  • FHIT gene therapy represents a potential novel clinical strategy for cancer intervention.
  • This approach could be applicable for both early-stage cancer treatment and cancer prevention in humans.

More Related Videos

Constitutive and Inducible Systems for Genetic In Vivo Modification of Mouse Hepatocytes Using Hydrodynamic Tail Vein Injection09:35

Constitutive and Inducible Systems for Genetic In Vivo Modification of Mouse Hepatocytes Using Hydrodynamic Tail Vein Injection

Published on: February 2, 2018

CRISPR/Cas9-mediated Targeted Integration In Vivo Using a Homology-mediated End Joining-based Strategy08:22

CRISPR/Cas9-mediated Targeted Integration In Vivo Using a Homology-mediated End Joining-based Strategy

Published on: March 12, 2018

Related Concept Videos

In-vitro Mutagenesis01:16

In-vitro Mutagenesis

To learn more about the function of a gene, researchers can observe what happens when the gene is inactivated or “knocked out,” by creating genetically engineered knockout animals. Knockout mice have been particularly useful as models for human diseases such as cancer, Parkinson’s disease, and diabetes.
Gene Therapy00:59

Gene Therapy

Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be inserted. The...
Mouse Models of Cancer Study02:43

Mouse Models of Cancer Study

Mice have long served as models for studying human biology and pathology because of their phylogenetic and physiological similarity with humans. They are also easy to maintain and breed in the laboratory, and hence, many inbred strains are now available for research. Studies on mice have contributed immeasurably to our understanding of cancer biology.
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...